Trevena, Inc

(NASDAQ:TRVN)

Latest On Trevena, Inc (TRVN):

Date/Time Type Description Signal Details
2023-05-30 21:00 ESTNewsTrevena regains compliance with Nasdaq listing ruleN/A
2023-05-15 15:45 ESTNewsTrevena GAAP EPS of -$0.81N/A
2023-05-15 15:45 ESTNewsTrevena, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-15 15:45 ESTNewsTrevena, Inc. (TRVN) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 16:12 ESTNewsTrevena stock jumps ~20% as partner gets Chinese approval for pain drug OlinvykN/A
2023-04-01 02:47 ESTNewsTrevena, Inc. (TRVN) Q4 2022 Earnings Call TranscriptN/A
2023-03-30 15:29 ESTNewsTrevena GAAP EPS of -$0.73 beats by $1.01N/A
2023-03-30 15:29 ESTNewsTrevena stock rises after opioid pain drug Olinvyk shows promise in real-world studiesN/A
2022-11-29 13:52 ESTNewsTrevena regains compliance with Nasdaq minimum bid price listing ruleN/A
2022-11-16 18:55 ESTNewsTrevena launches $8M securities offeringN/A
2022-11-13 23:47 ESTNewsTrevena, Inc. (TRVN) Q3 2022 Results - Earnings Call TranscriptN/A
2022-11-10 06:41 ESTNewsTrevena slides 18% after the bell on 1-for-25 reverse stock splitN/A
2022-11-09 13:29 ESTNewsTrevena GAAP EPS of -$0.09 in-line, revenue of -$0.44M misses by $0.88MN/A
2022-11-08 20:08 ESTNewsTrevena Q3 2022 Earnings PreviewN/A
2022-08-15 22:39 ESTNewsTrevena, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-13 02:05 ESTNewsTrevena, Inc's (TRVN) CEO Carrie Bourdow on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 16:40 ESTNewsTrevena GAAP EPS of -$0.09 beats by $0.01N/A
2022-08-11 16:39 ESTNewsTrevena (TRVN) Investor Presentation - SlideshowN/A
2022-08-11 00:32 ESTNewsTrevena Q2 2022 Earnings PreviewN/A
2022-07-29 19:19 ESTNewsTrevena slides on $2M preferred stock offeringN/A
2022-07-28 15:09 ESTNewsTrevena ends Syneos sales contract, reduces staff to extend cash runwayN/A
2022-05-14 04:27 ESTNewsTrevena, Inc. (TRVN) CEO Carrie Bourdow on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-11 11:17 ESTNewsTrevena GAAP EPS of -$0.10, revenue of $0.02MN/A
2022-05-11 11:16 ESTNewsTrevena stock falls 30% as Q1 net loss widens Y/YN/A
2022-05-10 15:25 ESTNewsTrevena Q1 2022 Earnings PreviewN/A
2022-04-20 19:32 ESTNewsTrevena reports data on effect of opioid pain drug Olinvyk on respiratory function in elderly/overweightN/A
2022-03-31 19:49 ESTNewsTrevena GAAP EPS of -$0.08 beats by $0.02N/A
2022-03-31 19:49 ESTNewsTrevena stock soars 30% amid Q4 results, $40M financing on pain drug OlinvykN/A
2022-03-31 19:48 ESTNewsTrevena, Inc.'s (TRVN) CEO Carrie Bourdow on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-31 01:02 ESTNewsTrevena Q4 2021 Earnings PreviewN/A
2021-12-14 03:40 ESTNewsTrevena Offers An Enticing Risk-Reward At These PricesN/A
2021-12-13 08:31 ESTNewsTrevena moves diabetic neuropathic pain candidate into phase 1N/A
2021-11-15 13:56 ESTNewsTrevena EPS beats by $0.01, misses on revenueN/A
2021-11-15 13:55 ESTNewsTrevena, Inc. (TRVN) CEO Carrie Bourdow on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-14 06:24 ESTNewsWarning: TRVN is at high risk of performing badlyN/A
2021-10-01 00:14 ESTNewsTrevena’s experimental COVID-19 therapy cuts hospital stay by 12 days - studyN/A
2021-08-26 01:49 ESTNewsWake Forest Baptist Health Medical Center to join Trevena's OLINVYK studyN/A
2021-08-17 02:04 ESTNewsTrevena: Remaining Patient After A Disappointing Q2 EarningsN/A
2021-08-13 22:13 ESTNewsTrevena, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-13 01:44 ESTNewsTrevena EPS misses by $0.02, misses on revenueN/A
2021-08-13 01:41 ESTNewsTrevena's (TRVN) CEO Carrie Bourdow on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-26 23:32 ESTNewsTrevena enrolls first patient in NIH funded COVID-19 trialN/A
2021-07-22 04:41 ESTNewsTrevena announces resumption of NIH-run trial for TRV734 in opioid use disorderN/A
2021-07-22 04:26 ESTNewsTrevena added to Russell 2000, Russell 3000, and Russell Microcap IndexesN/A
2021-07-22 04:26 ESTNewsTrevena shares fall after reverse stock split proposalN/A
2021-07-22 04:18 ESTNewsTrevena launches Phase 1 Olinvyk respiratory physiology study in elderly/obese subjectsN/A
2021-07-22 04:17 ESTNewsTrevena enrolls first patient in OLINVYK late-stage trial in ChinaN/A
2021-05-06 20:26 ESTNewsTrevena EPS beats by $0.02, misses on revenueN/A
2021-05-06 00:29 ESTNewsTrevena: Taking A Systematic Approach With A Speculative InvestmentN/A
2021-04-22 02:37 ESTNewsTrevena shares rise 10% on selection of TRV027 in global COVID-19 trialN/A

About Trevena, Inc (TRVN):

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist that has completed Phase I clinical study for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR that has completed Phase I clinical study for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. The company has a collaboration with Imperial College London to evaluate Trv027 in Covid-19 patients. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.

TRVN Quotes by TradingView

See Advanced Chart

General

  • Name Trevena, Inc
  • Symbol TRVN
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 25
  • Fiscal Year EndDecember
  • IPO Date2014-01-31
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.trevena.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 87.74
  • Price/Book (Most Recent Quarter) 3.27
  • Enterprise Value Revenue 77.77
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.31
  • Next Year EPS Estimate -$0.20
  • Next Quarter EPS Estimate -$0.06
  • Operating Margin -961%
  • Return on Assets -21%
  • Return on Equity -44%
  • Revenue 3.07 million
  • Earnings Per Share -$0.26
  • Revenue Per Share $0.02
  • Gross Profit 2.89 million
  • Quarterly Earnings Growth 122.6%
View More

Highlights

  • Market Capitalization 324.16 million
  • EBITDA -21353000
  • Analyst Target Price $5.25
  • Book Value Per Share $0.65
View More

Share Statistics

  • Shares Outstanding 157.03 million
  • Shares Float 159.45 million
  • % Held by Insiders 158%
  • % Held by Institutions 11.65%
  • Shares Short 18.73 million
  • Shares Short Prior Month 18.83 million
  • Short Ratio 4.57
  • Short % of Float 12%
  • Short % of Shares Outstanding 12%
View More

Technicals

  • Beta 2.51
  • 52 Week High $3.68
  • 52 Week Low $0.46
  • 50 Day Moving Average 2.3
  • 200 Day Moving Average 2.4
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Trevena, Inc (TRVN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Trevena, Inc (TRVN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$69000-$0.08-$0.07-19.94%
2020-09-302020-11-02$N/A-$0.04-$0.0514.35%
2020-06-302020-08-10$N/A-$0.06-$0.060%
2020-03-312020-05-07$N/A-$0.06-$0.060%
2019-12-312020-03-12$31000-$0.07-$0.0917.65%
2019-09-302019-11-04$N/A-$0.09-$0.08-20%
2019-06-302019-08-07$N/A-$0.05-$0.0837.5%
2019-03-312019-05-10$N/A-$0.06-$0.0929.41%
2018-12-312019-03-13$232000-$0.10-$0.08-33.33%
2018-09-302018-11-08$3 million-$0.06-$0.1353.85%
2018-06-302018-08-02$2.5 million-$0.13-$0.12-6.12%
2018-03-312018-05-03$N/A-$0.14-$0.2031.14%
2017-12-312018-03-07$N/A-$0.24-$0.2710.55%
2017-09-302017-11-07$N/A-$0.27-$0.3318.67%
2017-06-302017-08-03$N/A-$0.35-$0.362.78%
2017-03-312017-05-04$N/A-$0.36-$0.5433.49%
2016-12-312017-03-08$3.75 million-$0.67-$0.61-10.14%
2016-09-302016-11-03$-1875000-$0.57-$0.40-42.89%
2016-06-302016-08-04$1.88 million-$0.37-$0.36-2.41%
2016-03-312016-05-05$1.88 million-$0.35-$0.32-10.86%
2015-12-312016-03-09$1.88 million-$0.30-$0.25-19.33%
2015-09-302015-11-10$1.88 million-$0.24-$0.3429.41%
2015-06-302015-08-11$1.88 million-$0.28-$0.3826.32%
2015-03-312015-05-07$625000-$0.33-$0.368.33%
2014-12-312015-03-18$N/A-$0.44-$0.5215.38%
2014-09-302014-11-11$N/A-$0.59-$0.45-31.11%
2014-06-302014-08-12$N/A-$0.44-$0.39-12.82%
2014-03-312014-05-09$N/A-$0.59-$0.34-73.53%
2013-12-312014-03-20$135000-$7.48-$0.51-1366.67%

Trevena, Inc (TRVN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Trevena, Inc (TRVN) Chart:

Trevena, Inc (TRVN) News:

Below you will find a list of latest news for Trevena, Inc (TRVN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Trevena, Inc (TRVN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-03-212.50.05CALL0 70253.18FALSE00
2025-03-2150CALL0 00FALSE00
2025-03-217.50CALL0 00FALSE00
2025-03-212.50PUT0 00TRUE00
2025-03-2150PUT0 0335.06TRUE00
2025-03-217.50PUT0 0316.68TRUE00

Latest TRVN Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$0.4087
Jun 13, 2022 7:59 PM EST123$0.4081
Jun 13, 2022 7:59 PM EST115$0.4081
Jun 13, 2022 7:59 PM EST36$0.4081
Jun 13, 2022 7:59 PM EST9$0.412

Trevena, Inc (TRVN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919120039247/0001209191-20-039247-index.htm
2018-06-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1429560/000000000018019143/0000000000-18-019143-index.htm
2018-11-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1429560/000031506618002474/0000315066-18-002474-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1429560/000090221919000018/0000902219-19-000018-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1429560/000090221919000025/0000902219-19-000025-index.htm
2020-08-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1429560/000104746920004516/0001047469-20-004516-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1429560/000104746920004571/0001047469-20-004571-index.htm
2018-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465918034792/0001104659-18-034792-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465918039754/0001104659-18-039754-index.htm
2018-06-1410-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1429560/000110465918040166/0001104659-18-040166-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465918040481/0001104659-18-040481-index.htm
2018-06-15S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1429560/000110465918040485/0001104659-18-040485-index.htm
2018-06-26CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1429560/000110465918042339/0001104659-18-042339-index.htm
2018-06-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1429560/000110465918043238/0001104659-18-043238-index.htm
2018-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465918048969/0001104659-18-048969-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465918059743/0001104659-18-059743-index.htm
2018-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465918061470/0001104659-18-061470-index.htm
2018-10-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465918061694/0001104659-18-061694-index.htm
2018-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465918062516/0001104659-18-062516-index.htm
2018-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465918065733/0001104659-18-065733-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465918066807/0001104659-18-066807-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465918074274/0001104659-18-074274-index.htm
2019-01-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1429560/000110465919001254/0001104659-19-001254-index.htm
2019-01-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919003509/0001104659-19-003509-index.htm
2019-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919004283/0001104659-19-004283-index.htm
2019-02-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1429560/000110465919004956/0001104659-19-004956-index.htm
2019-02-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919004957/0001104659-19-004957-index.htm
2019-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919007105/0001104659-19-007105-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919011976/0001104659-19-011976-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919013379/0001104659-19-013379-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919014419/0001104659-19-014419-index.htm
2019-04-02DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1429560/000110465919019353/0001104659-19-019353-index.htm
2019-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919021992/0001104659-19-021992-index.htm
2019-04-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1429560/000110465919022000/0001104659-19-022000-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919028422/0001104659-19-028422-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919030148/0001104659-19-030148-index.htm
2019-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919037759/0001104659-19-037759-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919044404/0001104659-19-044404-index.htm
2019-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919049117/0001104659-19-049117-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919059198/0001104659-19-059198-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465919070807/0001104659-19-070807-index.htm
2020-01-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1429560/000110465920004740/0001104659-20-004740-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920012826/0001104659-20-012826-index.htm
2020-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920021655/0001104659-20-021655-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920028825/0001104659-20-028825-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920029434/0001104659-20-029434-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920032752/0001104659-20-032752-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920038498/0001104659-20-038498-index.htm
2020-04-01PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1429560/000110465920041830/0001104659-20-041830-index.htm
2020-04-13DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1429560/000110465920045924/0001104659-20-045924-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920048458/0001104659-20-048458-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920057721/0001104659-20-057721-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920062599/0001104659-20-062599-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920062925/0001104659-20-062925-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920063268/0001104659-20-063268-index.htm
2020-05-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920065859/0001104659-20-065859-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920068647/0001104659-20-068647-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920092325/0001104659-20-092325-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920093313/0001104659-20-093313-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920094198/0001104659-20-094198-index.htm
2020-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920119746/0001104659-20-119746-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1429560/000110465920120288/0001104659-20-120288-index.htm
2018-11-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1429560/000114420418058438/0001144204-18-058438-index.htm
2020-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000119248220000769/0001192482-20-000769-index.htm
2019-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1429560/000119312519039116/0001193125-19-039116-index.htm
2018-05-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919118032660/0001209191-18-032660-index.htm
2018-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919118032663/0001209191-18-032663-index.htm
2018-06-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919118037457/0001209191-18-037457-index.htm
2018-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919118049241/0001209191-18-049241-index.htm
2018-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919118052738/0001209191-18-052738-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919118052746/0001209191-18-052746-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919118052751/0001209191-18-052751-index.htm
2018-12-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919118061520/0001209191-18-061520-index.htm
2018-12-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919118061522/0001209191-18-061522-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919118061799/0001209191-18-061799-index.htm
2018-12-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919118061807/0001209191-18-061807-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919118061809/0001209191-18-061809-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119006652/0001209191-19-006652-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119007160/0001209191-19-007160-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119007388/0001209191-19-007388-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119030516/0001209191-19-030516-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119030517/0001209191-19-030517-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119030520/0001209191-19-030520-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119030525/0001209191-19-030525-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119030527/0001209191-19-030527-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119030529/0001209191-19-030529-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119030532/0001209191-19-030532-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119030546/0001209191-19-030546-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119034350/0001209191-19-034350-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119034354/0001209191-19-034354-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119034359/0001209191-19-034359-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119034361/0001209191-19-034361-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119039298/0001209191-19-039298-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119039299/0001209191-19-039299-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119050267/0001209191-19-050267-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119050268/0001209191-19-050268-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119050269/0001209191-19-050269-index.htm
2019-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119059132/0001209191-19-059132-index.htm
2019-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119059135/0001209191-19-059135-index.htm
2019-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119059136/0001209191-19-059136-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119060478/0001209191-19-060478-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119060480/0001209191-19-060480-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119060482/0001209191-19-060482-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919119060486/0001209191-19-060486-index.htm
2020-02-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919120008788/0001209191-20-008788-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919120008794/0001209191-20-008794-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919120029765/0001209191-20-029765-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919120029769/0001209191-20-029769-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919120029773/0001209191-20-029773-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919120029775/0001209191-20-029775-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919120029779/0001209191-20-029779-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919120029782/0001209191-20-029782-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919120029786/0001209191-20-029786-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919120029791/0001209191-20-029791-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1429560/000120919120039247/0001209191-20-039247-index.htm
2019-02-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1429560/000153561019000065/0001535610-19-000065-index.htm
2020-01-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1429560/000153561020000006/0001535610-20-000006-index.htm
2018-08-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1429560/000155837018006159/0001558370-18-006159-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1429560/000155837018008923/0001558370-18-008923-index.htm
2019-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1429560/000155837019001898/0001558370-19-001898-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1429560/000155837019004773/0001558370-19-004773-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1429560/000155837019007366/0001558370-19-007366-index.htm
2019-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1429560/000155837019009747/0001558370-19-009747-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1429560/000155837020002472/0001558370-20-002472-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1429560/000155837020005537/0001558370-20-005537-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1429560/000155837020010027/0001558370-20-010027-index.htm
2020-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1429560/000155837020012186/0001558370-20-012186-index.htm
2018-06-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1429560/999999999518001677/9999999995-18-001677-index.htm
2018-06-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1429560/999999999718006510/9999999997-18-006510-index.htm

Trevena, Inc (TRVN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Trevena, Inc (TRVN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 158%
Institutional Ownership: 1165%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-02-01LEON O JR MOULDERDirectorBuy100,000.001.02102,000.00100,000.00https://www.sec.gov/Archives/edgar/data/1429560/000120919119006652/0001209191-19-006652-index.htm
2018-12-06Robert T YoderSr. VP, Chief Business OfficerBuy100,000.00100,000.00https://www.sec.gov/Archives/edgar/data/1429560/000120919118061809/0001209191-18-061809-index.htm
2018-12-06Mark DemitrackSr VP & Chief Medical OfficerBuy125,000.00125,000.00https://www.sec.gov/Archives/edgar/data/1429560/000120919118061522/0001209191-18-061522-index.htm
2020-02-10Scott ApplebaumCLCO; SVP Regulatory AffairsBuy250,000.00250,000.00https://www.sec.gov/Archives/edgar/data/1429560/000120919120008794/0001209191-20-008794-index.htm
2019-12-12Robert T YoderSr. VP, Chief Business OfficerBuy167,000.00253,254.00https://www.sec.gov/Archives/edgar/data/1429560/000120919119060486/0001209191-19-060486-index.htm
2018-12-06Carrie L. BourdowPresident and CEOBuy250,000.00254,500.00https://www.sec.gov/Archives/edgar/data/1429560/000120919118061520/0001209191-18-061520-index.htm
2019-06-25Barry ShinChief Financial OfficerBuy275,000.00275,000.00https://www.sec.gov/Archives/edgar/data/1429560/000120919119039299/0001209191-19-039299-index.htm
2019-02-01Carrie L. BourdowPresident and CEOBuy50,000.001.0251,000.00304,500.00https://www.sec.gov/Archives/edgar/data/1429560/000120919119007160/0001209191-19-007160-index.htm
2019-12-12Mark DemitrackSr. VP & Chief Medical OfficerBuy213,000.00320,038.00https://www.sec.gov/Archives/edgar/data/1429560/000120919119060482/0001209191-19-060482-index.htm
2019-12-12Barry ShinChief Financial OfficerBuy194,000.00469,000.00https://www.sec.gov/Archives/edgar/data/1429560/000120919119060478/0001209191-19-060478-index.htm
2019-02-01MAXINE GOWENPresident & CEOBuy50,000.001.0251,000.0054,000.00https://www.sec.gov/Archives/edgar/data/1429560/000120919119007388/0001209191-19-007388-index.htm
2018-12-06John P. HamillVP Fin,Princ Fin&Acct OfficerBuy80,000.0080,250.00https://www.sec.gov/Archives/edgar/data/1429560/000120919118061799/0001209191-18-061799-index.htm
2019-05-31John P. HamillVP Fin,Princ Fin&Acct OfficerBuy7,500.001.168,700.0087,750.00https://www.sec.gov/Archives/edgar/data/1429560/000120919119034359/0001209191-19-034359-index.htm
2019-12-12Carrie L. BourdowPresident and CEOBuy657,000.00925,894.00https://www.sec.gov/Archives/edgar/data/1429560/000120919119060480/0001209191-19-060480-index.htm